Oxford Global R&D Series EU
About the event
11 – 12 June 2019 – Berlin – Germany
Oxford Global’s R&D Europe Series features 4 outstanding programmes: the 20th Annual Drug Discovery Summit, 7th Annual Discovery Chemistry & Drug Design Congress, Bispecific in Discovery & Development Congress and the Neuroscience in Discovery & Development Congress. The R&D Europe Series unites over 400 drug discovery attendees from global pharmaceutical organisations, top biotech companies and internationally renowned academic institutions specialising in various therapeutic areas. This renowned series of events provide a valuable opportunity for leaders to transform and lead the future of drug discovery and development.
As a part of the R&D Series: 7th Annual Discovery Chemistry & Drug Design Congress: Bringing you the latest in discovery enabling technologies, computational based drug design and discovery chemistry, this congress bring together leading figures in the field to discuss the evolving techniques being utilised in the sector. Key focus areas include; DNA encoded libraries, protein-protein interactions, AI/ML in drug design and medicinal chemistry for oncology.
As a leading contract research organization in discovery chemistry and custom synthesis, Taros provides comprehensive solutions to meet our clients’ needs from diverse branches and applications
Our experienced chemists practice a pragmatic culture and customer-centric approach in order to exceed project expectations, despite challenges, bridging very narrow timelines. They are trained to consider economic, safety and ecological boundaries and conditions laid out for all stages of the project, starting from the development of synthetic routes to…